Day One Biopharmaceuticals Growth Metrics (2022-2025) | DAWN

1Y3Y5Y7Y10YAll
Download Data
Growth Metrics Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
Assets Growth (1y) 20.83%11.56%8.46%7.73%0.95%-11.16%45.06%54.98%63.59%29.62%-14.49%
Assets Growth (3y) 25.90%8.71%10.40%
Assets (QoQ) 50.89%-5.49%-8.59%-7.31%39.31%-8.11%-9.21%-13.14%22.59%50.04%-3.00%-8.31%-2.87%-1.01%
Capital Expenditures Growth (1y) 73.33%2,028.57%925.00%36,812.75%-132,417.07%240,525.00%-103.05%
Capital Expenditures Growth (3y) 410.87%-523.17%
Capital Expenditures (QoQ) -53.33%-42.86%473.08%-72.48%-80.49%-198.64%135.48%-89.61%-184.00%
Cash & Equivalents Growth (1y) -81.25%-51.34%99.55%170.68%448.82%26.64%75.29%-45.85%-87.66%-85.13%-89.76%
Cash & Equivalents Growth (3y) -49.74%-54.92%-28.99%
Cash & Equivalents (QoQ) 48.01%-68.92%-29.46%-42.22%284.04%27.47%-4.31%17.16%-11.38%76.43%-70.44%-73.31%6.79%21.49%
Cash from Investing Activities Growth (1y) -74,520.00%438.07%136.02%1,474.66%897.71%-15.87%-176.14%-987.56%-136.53%54.32%119.88%
Cash from Investing Activities Growth (3y) -1,195.49%85.56%27.13%
Cash from Investing Activities (QoQ) -39,880.00%-4,016.26%99.10%-406.47%281.13%338.58%-65.83%193.90%-80.90%-496.90%-298.29%87.90%180.71%-48.86%
Cash from Operations Growth (1y) -20.51%-42.45%-59.66%-17.17%-91.38%-15.78%236.93%27.47%-18.64%49.51%-111.44%
Cash from Operations Growth (3y) -39.86%5.92%37.00%
Cash from Operations (QoQ) -38.14%22.07%-52.11%26.41%-63.29%12.65%-11.62%-20.20%1.21%203.31%-159.13%-96.60%57.95%76.60%
EBITDA Margin Growth (1y) 129,831.00-9255.00
EBITDA Margin (QoQ) 143,306.00-25529.009,017.003,036.004,220.00
EBIT Growth (1y) -150.37%157.61%-9.77%38.49%69.54%-181.83%
EBIT Margin Growth (1y) 129,831.00-9255.00
EBIT Margin (QoQ) 143,306.00-25529.009,017.003,036.004,220.00
EBIT (QoQ) -12.18%-15.71%-12.18%-71.95%125.81%-320.45%37.14%14.84%30.66%
EBT Growth (1y) -161.49%175.75%-8.78%42.35%72.66%-156.33%
EBT Margin Growth (1y) 126,372.00-8677.00
EBT Margin (QoQ) 139,037.00-24024.008,601.002,758.003,988.00
EBT (QoQ) -8.87%-18.09%-14.51%-77.63%131.54%-269.57%39.32%15.76%35.02%
Enterprise Value Growth (1y) 89.20%-39.45%-39.69%-27.09%69.10%93.39%0.38%-17.52%-70.62%-75.57%-59.26%
Enterprise Value Growth (3y) -2.04%-34.11%-37.29%
Enterprise Value (QoQ) 104.46%52.51%13.07%-46.34%-34.57%51.90%36.70%24.45%-25.17%-21.16%12.33%-55.67%-37.79%31.50%
EPS (Basic) Growth (1y) 91.53%170.37%-7.81%51.39%-480.00%-150.00%
EPS (Basic) (QoQ) 8.47%-18.52%-12.50%93.06%860.00%-281.58%49.28%17.14%34.48%
EPS (Weighted Average and Diluted) Growth (1y) 91.53%170.37%-7.81%51.39%-480.00%-150.00%
EPS (Weighted Average and Diluted) (QoQ) 8.47%-18.52%-12.50%93.06%860.00%-281.58%49.28%17.14%34.48%
FCF Margin Growth (1y) 120,290.00-12658.00
FCF Margin (QoQ) 138,310.00-28064.00-2965.0013,009.005,361.00
Free Cash Flow Growth (1y) -20.54%-42.92%-59.81%-17.19%-91.18%-144.54%382.99%-19.04%-22.66%77.79%-105.53%
Free Cash Flow Growth (3y) -41.39%8.10%37.00%
Free Cash Flow (QoQ) -38.08%22.07%-52.08%26.34%-63.70%12.86%-11.52%-20.18%-109.39%200.84%-146.91%-23.83%62.09%74.90%
Net Cash Flow Growth (1y) -66.81%10.94%119.39%70.80%210.04%-121.99%252.43%-2,764.81%-331.30%107.36%-95.82%
Net Cash Flow Growth (3y) -61.92%-73.82%26.59%
Net Cash Flow (QoQ) 684.60%-312.46%86.72%-1.10%488.80%-62.86%-120.00%481.02%-177.70%695.12%-262.60%69.24%102.47%238.12%
Net Income Growth (1y) -165.16%177.66%-20.61%42.35%73.04%-154.94%
Net Income (QoQ) -8.87%-18.09%-14.51%-80.12%131.89%-283.38%45.27%15.76%35.02%
Net Income towards Common Stockholders Growth (1y) -165.16%177.66%-20.61%42.35%73.04%-154.94%
Net Income towards Common Stockholders (QoQ) -8.87%-18.09%-14.51%-80.12%131.89%-283.38%45.27%15.76%35.02%
Net Margin Growth (1y) 128,267.00-8771.00
Net Margin (QoQ) 141,026.00-26325.0010,808.002,758.003,988.00
Operating Income Growth (1y) -150.37%157.61%-9.77%38.49%69.54%-181.83%
Operating Income (QoQ) -12.18%-15.71%-12.18%-71.95%125.81%-320.45%37.14%14.84%30.66%
Operating Margin Growth (1y) 129,831.00-9255.00
Operating Margin (QoQ) 143,306.00-25529.009,017.003,036.004,220.00
Profit After Tax Growth (1y) 89.60%180.25%-20.55%42.33%-588.04%-153.26%
Profit After Tax (QoQ) -8.86%-18.12%-14.49%92.94%940.41%-277.43%45.22%15.76%34.94%
Property, Plant & Equipment (Net) Growth (1y) 9.09%173.13%508.57%940.00%156.94%7.10%324.41%998.56%1,255.68%1,082.14%146.35%
Property, Plant & Equipment (Net) Growth (3y) 236.20%225.80%299.22%
Property, Plant & Equipment (Net) (QoQ) 1.52%-47.76%-42.86%260.00%154.17%16.39%-2.35%-11.06%5.95%361.22%152.77%9.76%-7.62%-3.88%
Return on Assets Growth (1y) 27.0058.009.00
Return on Assets (QoQ) -17.0037.004.003.0014.00-11.00
Return on Capital Employed Growth (1y) 32.0085.0010.00
Return on Capital Employed (QoQ) -39.0063.004.004.0014.00-13.00
Return on Equity Growth (1y) 28.0071.0012.00
Return on Equity (QoQ) -27.0046.006.002.0016.00-13.00
Return on Sales (QoQ) 59.00-62.00
Revenue Growth (1y) 313.92%-57.56%
Revenue (QoQ) 1,044.54%-68.85%5.32%10.23%17.36%
Share-based Compensation Growth (1y) 52.32%68.30%12.01%58.22%33.84%37.49%20.28%2.07%1.72%-16.36%-17.25%
Share-based Compensation Growth (3y) 27.52%24.62%3.69%
Share-based Compensation (QoQ) -9.21%52.30%-20.32%38.26%0.32%1.36%12.54%16.95%3.05%-11.33%-4.49%16.55%-15.26%-12.27%
Shareholder's Equity Growth (1y) 15.72%9.07%7.31%4.37%-1.20%-28.01%42.56%45.08%61.56%50.24%-18.83%
Shareholder's Equity Growth (3y) 22.70%5.66%7.49%
Shareholder's Equity (QoQ) 50.47%-7.05%-8.55%-9.52%41.82%-8.55%-11.06%-14.35%3.34%81.09%-9.49%-4.62%-3.90%-2.16%